ADVANCED VIRAL RESEARCH CORP
S-1/A, EX-27.1, 2000-12-15
PHARMACEUTICAL PREPARATIONS
Previous: ADVANCED VIRAL RESEARCH CORP, S-1/A, EX-23.1, 2000-12-15
Next: IDEX SERIES FUND, 485APOS, 2000-12-15



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENT OF OPERATIONS OF ADVANCED
VIRAL RESEARCH CORP. FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       1,342,650
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     19,729
<CURRENT-ASSETS>                             1,441,959
<PP&E>                                       1,737,185<F1>
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               3,907,189
<CURRENT-LIABILITIES>                        1,037,297
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         3,619
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 3,907,189
<SALES>                                          7,285
<TOTAL-REVENUES>                                 7,285
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             5,762,920
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             898,901
<INCOME-PRETAX>                             (6,546,622)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (6,546,622)
<EPS-BASIC>                                      (0.02)
<EPS-DILUTED>                                    (0.02)
<FN>
<F1>PP&E VALUES REPRESENT NET AMOUNTS
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission